Vanquis Banking Group PLC (VANQ)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 70.50 |
|---|---|
| 52-week range | 66.50 – 132.00 |
| Return, 1 month / 3 months | −3.3% / −40.9% |
| Return, 1 year / 3 years | −37.5% / −37.9% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 41.9% |
| Worst drawdown (1 year) | -48.4% |
| Average daily value traded | 82.15M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Vanquis Banking Group is a British financial services company based in the United Kingdom. It provides credit cards and personal loans, mainly to customers who may find it difficult to borrow from mainstream banks. Its brands include Vanquis, which offers consumer credit cards, and Moneybarn, which provides finance for used vehicles. The group serves individual borrowers across the United Kingdom through its lending products and related services.
On this site Vanquis Banking Group PLC appears as a stock on the London Exchange (UK), code VANQ, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Vanquis Banking Group PLC (VANQ) trades on the London Exchange in UK. It last closed at GBX 70.50 on 23 October 2026.
Its price-based Market X-Ray is 28 out of 100 (a weak price profile), ranking 3,167 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 37.5% and over the last three months it fell 40.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 9 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -31.6% | ||
| From 52-week high | -46.1% | ||
| Momentum | 7 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -40.9% | ||
| 6-month return | -36.5% | ||
| 12-month return, skipping the last month | -35.4% | ||
| Stability (higher is calmer) | 30 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 41.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -48.4% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 82.15M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +4.3% |
|---|---|
| 1 month | −3.3% |
| 3 months | −40.9% |
| 6 months | −36.5% |
| 1 year | −37.5% |
| 3 years | −37.9% |
| 5 years | −76.3% |
Signals
| 50-day / 200-day average | 74.76 / 103.11 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 2.63 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Apr 2024 | GBP 0.0100 |
| 10 Aug 2023 | GBP 0.0500 |
| 20 Apr 2023 | GBP 0.1030 |
| 11 Aug 2022 | GBP 0.0500 |
| 21 Apr 2022 | GBP 0.1200 |
| 2 Apr 2020 | GBP 0.1600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.